Scott Koenig - 15 Feb 2025 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
President and CEO, Director
Signature
Beth A. Smith, Attorney-in-fact
Issuer symbol
MGNX
Transactions as of
15 Feb 2025
Net transactions value
$0
Form type
4
Filing time
19 Feb 2025, 16:28:50 UTC
Previous filing
11 Feb 2025
Next filing
15 Aug 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGNX Common Stock Options Exercise $0 +42,329 +5.8% $0.000000 777,415 15 Feb 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGNX Restricted Stock Unit Options Exercise $0 -42,329 -50% $0.000000 42,330 15 Feb 2025 Common Stock 42,329 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 15, 2023 the reporting person was granted 127,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.